Toxemia  >>  Cubicin (daptomycin)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00942149: An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants

Completed
1
20
US
Daptomycin
Duke University
Sepsis
12/11
12/11

Download Options